Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments
 Oncology API
 Specialty APIs
 Chiral intermediates

 1,2-Amino Alcohols

 1,2-Amino Alcohols Oxazolidinones

 Monosaccharides Derivatives

 Tartaric Acid Derivatives

Monosaccharides Derivatives
3-o-acetyl-1,2:5,6-di-o-isopropylidene-α-d-glucofuranose C14H22O7/ 302.33
1,2-o-isopropylidene-α-d-glucofuranose C9H16O6/ 220.22
3-o-benzyl-1,2:5,6-di-o-isopropylidene-α-d-glucofuranose C19H26O6/ 350
1,2,3,4,6-penta-o-acetyl-α-d-glucopyranose C16H22O11/ 390.35
3-o-benzyl-1,2-o-isopropylidene-α-d-xylo-dialdose C15H18O5/ 280.28
Β-d-glucose pentacetate C16H22O11/ 390.34
1,2:5,6-di-cyclohexylidene-α-d-glucofuranose C18H28O6/ 340.42
1,2-o-cyclohexylidene-α-d-glucofuranose C12H20O6/ 260
3-o-benzyl-1,2:5,6-di-o-cyclohexylidene-α-d-glucofuranose C25H34O6/ 430.4
1,2:5,6-di-isopropylidene-α-d-glucofuranose C12H20O6/ 260.29
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.